SecBot SecBot
Insider Cluster (4 insiders) ·Filed Mar 5, 2026

DGX

QUEST DIAGNOSTICS INC
BEARISH
Impact 7/10
Horizondays Processed8mo ago
Insider cluster: 3 insiders, $2.5M total
Actionable Insight ▼ Bearish

Traders should monitor for potential downward pressure on DGX shares, especially if no offsetting institutional buying emerges. The concentration of C-suite selling on a single day is a negative signal, particularly in absence of recent positive news.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$203.09
T+0 close · Mar 4, 2026 · via day close
Latest settled
−5.36%
T+60 · $192.20
Vs SPY
−16.66%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 5 $203.09entry
  2. T+1 · 9mo ago −2.34%α −1.03% · $198.34
  3. T+5 · 8mo ago −1.52%α +0.72% · $200.01
  4. T+20 · 8mo ago −2.92%α +0.87% · $197.16
  5. T+60 · 6mo ago −5.36%α −16.66% · $192.20
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Quest Diagnostics executives sold shares in a coordinated open-market transaction on March 5, 2026, totaling approximately $2.53 million. The sales were conducted at $206.21 per share and represent a material insider selling cluster. A director also received a non-cash award of 215 shares on March 9.

Key Financial Metrics

Direction
selling
Total Value
$2.5M
Insiders
4

Key Facts

  • SVP Patrick Plewman sold 2,855 shares for $588,729.55
  • EVP Catherine Doherty sold 5,558 shares for $1,146,115.18
  • SVP Michael Prevoznik sold 3,878 shares for $799,682.38
  • Total open-market sales: $2,534,527.11 across three C-suite executives
  • All sales occurred on March 5, 2026, at $206.21 per share
  • Director Timothy Wentworth received 215 shares via non-cash grant on March 9, 2026

Financial Impact

$2.53 million in open-market insider sales, representing ~0.011% of Quest Diagnostics' $22.1B market cap

insider sentimentshareholder confidence

Risk Factors

  • Insider selling may indicate lack of confidence in near-term performance or valuation
  • Potential for negative market perception leading to short-term share price weakness

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-DGX-1773266891498

US Market Status

Market Closed · Opens Wed (13h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 11, 2026